PETER WALSH

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology BOZEMAN, MT NPI 1255372736

General Payments — all program years on this page

$1,213.78

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $337.95 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $337.9517

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $53.473
2019 $233.8110
2020 $19.391
2021 $86.185
2022 $160.329
2023 $322.6614
2024 $337.9517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078814102 Janssen Biotech, Inc. $13.71 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078814428 Janssen Biotech, Inc. $13.72 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078814441 Janssen Biotech, Inc. $20.25 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078814496 Janssen Biotech, Inc. $28.21 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091984269 Ipsen Biopharmaceuticals, Inc $27.64 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091984271 Ipsen Biopharmaceuticals, Inc $21.04 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101184767 Celgene Corporation $18.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101184777 Celgene Corporation $47.49 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101184779 Celgene Corporation $19.79 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106302497 ABBVIE INC. $14.30 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106302499 ABBVIE INC. $14.42 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106302501 ABBVIE INC. $14.62 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106302503 ABBVIE INC. $15.62 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114243962 Regeneron Healthcare Solutions, Inc. $17.30 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137694246 Takeda Pharmaceuticals U.S.A., Inc. $14.89 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137694248 Takeda Pharmaceuticals U.S.A., Inc. $18.67 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139739896 GENZYME CORPORATION $18.28 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.